(Q54323593)

English

Phase II study of doxorubicin plus ifosfamide/mesna in patients with advanced breast cancer.

scientific article published in June 1990

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/2110860

title

Phase II study of doxorubicin plus ifosfamide/mesna in patients with advanced breast cancer. (English)

1 reference

stated in

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/2110860

1 reference

2

1 reference

stated in

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/2110860

author name string

Millward MJ

series ordinal

1

1 reference

stated in

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/2110860

Cantwell BM

series ordinal

3

1 reference

stated in

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/2110860

language of work or name

English

0 references

publication date

1 June 1990

1 reference

stated in

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/2110860

published in

Cancer

1 reference

stated in

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/2110860

volume

65

1 reference

stated in

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/2110860

page(s)

2421-2425

1 reference

stated in

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/2110860

issue

11

1 reference

stated in

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/2110860

cites work

Advanced breast cancer: high-dose chemotherapy and bone marrow autotransplants

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F1097-0142%2819900601%2965%3A11%3C2421%3A%3AAID-CNCR2820651103%3E3.0.CO%3B2-L

retrieved

21 January 2018

The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F1097-0142%2819900601%2965%3A11%3C2421%3A%3AAID-CNCR2820651103%3E3.0.CO%3B2-L

retrieved

21 January 2018

Identifiers

DOI

10.1002/1097-0142(19900601)65:11<2421::AID-CNCR2820651103>3.0.CO;2-L

1 reference

stated in

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/2110860

PubMed ID

2110860

1 reference

stated in

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/2110860

(Q54323593)

Phase II study of doxorubicin plus ifosfamide/mesna in patients with advanced breast cancer.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)